China's Xi Orders Probe of Vaccine Makers After Violation Found

The transcript discusses a fraudulent data incident involving Chengcheng biotechnology company related to rabies vaccines, leading to increased regulatory oversight in the Chinese vaccine industry. This incident is not isolated, as it feeds into existing consumer concerns about product safety in China, including past scandals with infant formula. The vaccine business, previously lucrative, is now facing stock price declines due to these concerns. Despite being somewhat insulated from the US-China trade war, the industry is experiencing increased scrutiny and uncertainty about its future.

What was the expected growth of the vaccine market in China over the next few years?

What concerns have arisen regarding the oversight of the vaccine industry following the scandal?